September 1, 2018
The first non-income biotech listed company in Hong Kong, Gou Lai Pharmaceutical (01672), announced its first interim results after trading on Friday (31). As of the end of June, the first half of the year turned profitable and the interim net profit was 34,125 million yuan (RMB, the same as before), the same period last year, the loss was 17,427 million yuan, earnings per share of 4.12 points, no interim dividends.
Earn 34.12 million yuan, income 飙 3 times
The performance of the song ceremony lost successfully losing, mainly due to the first recorded 263 …